Medical Evacuation During Sustained Acceleration (MEDUSA): Validating Critical Care During Simulated Point-to-Point Spaceflight
Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (AN12)

Original Source

https://sam.gov/opp/fb7e0b8c953e4cd1bd739508f2790c36/view
Timeline
    Description

    The Department of Defense, through the U.S. Army Medical Research Acquisition Activity, intends to award a sole source contract to KBR Wyle Services, LLC for the Phase II study titled “Medical Evacuation During Sustained Acceleration (MEDUSA): Validating Critical Care During Simulated Point-to-Point Spaceflight.” This study aims to assess the impacts of sustained acceleration on hemodynamics using a swine model, requiring the unique capabilities of KBR's large centrifuge, which is the only one in the U.S. suitable for such advanced animal research. The project is critical for developing Department of Defense capabilities for patient transport using commercial spacecraft and is set to run from August 2024 to September 2025, with funding from FY 2023-2024 RDT&E allocations. Interested parties must submit their capabilities in writing to the primary contact, James Clingan, at james.b.clingan.civ@health.mil by 10:00 AM EST on June 7, 2024.

    Point(s) of Contact
    James (Brandon) Clingan
    james.b.clingan.civ@health.mil
    Jeremy McMurry
    jeremy.l.mcmurry.civ@health.mil
    Files
    Title
    Posted
    A02. Part 06 - JA FAR Part 6 - _MEDUSA2 Bridge PTS - REDACTED_Redacted.pdf
    The document outlines a Justification and Approval for Other than Full and Open Competition for a sole source contract between the USAF 59th Medical Wing and Bridge Preclinical Testing Services (PTS) for the MEDUSA 2 research study, focusing on medical evacuation during sustained acceleration scenarios. The study aims to validate critical care protocols within simulated spaceflight conditions, utilizing swine models. It emphasizes the lack of existing research on medical practices during such unique circumstances and highlights the expertise of Bridge PTS in providing specialized animal research services. The contract is set for a performance period from August 2024 to September 2025, with funding from FY 2023-2024 RDT&E allocations. Extensive market research confirmed Bridge PTS as the sole provider capable of meeting the specialized needs of the project, with previous collaborations validating its capabilities. The justification cites potential duplication of costs and mission-critical risks if conducted elsewhere. With a focus on animal welfare, Bridge PTS will oversee veterinary care and data analysis during the project, underscoring the necessity of this partnership for successful project execution. Thus, the proposal aims to advance military medicine while ensuring compliance with federal regulations regarding competition and research practices.
    Similar Opportunities
    Development of Philips Lumify Ultrasound System
    Active
    Dept Of Defense
    The Department of Defense, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is seeking interested parties to develop the Philips Lumify ultrasound system for the Army Medical Materiel Development Activity (USAMMDA) at Fort Detrick, Maryland. The primary objective is to procure services for the modification and enhancement of the Lumify system to ensure it meets military specifications, including addressing cybersecurity risks and facilitating effective training for military personnel. This initiative aims to improve combat casualty care by enabling rapid and accurate diagnoses in austere environments, thereby reducing unnecessary medical evacuations. Interested organizations must submit their capability statements by 4 p.m. EST on October 2, 2024, to the designated Contract Specialist, Christopher Sult, at christopher.m.sult.civ@health.mil, with the anticipated contract expected to last twelve months and likely structured as a Firm-Fixed-Price type.
    RFI-Transportable Patient Biocontainment, Isolation, and Quarantine Systems
    Active
    Dept Of Defense
    The U.S. Department of Defense seeks innovative solutions for its Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection (JPM CBRN Protection) program. The requirement is for transportable biocontainment, isolation, and quarantine (BIQ) systems, or components thereof, to be used across various platforms such as ships, aircraft, wheeled vehicles, and field deployable systems. These systems are crucial in preventing the spread of biological threats and addressing public health emergencies. Modularity, scalability, and compatibility with existing healthcare infrastructure are key attributes the government seeks, along with strict adherence to safety and quality standards. The focus is on finding deployable and sustainable solutions to contain hazardous pathogens, with the potential for multiple system applications across different platforms. An upcoming Innovation Day on October 9th, 2024, will provide an opportunity for interested parties to discuss their technologies and gain a deeper understanding of the government's requirements. Per the request, responses must be submitted via email to Brian Liska at brian.liska@usmc.mil by November 8th, 2024, at 5:00 p.m. EST. The contact email is brian.liska@usmc.mil, and further details can be found on the SAM.gov website.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE Combat Readiness - Medical, Translational Research Award: The Department of Defense (DoD) is soliciting extramural research and development ideas through the Congressionally Directed Medical Research Programs (CDMRP) Fiscal Year 2024 Combat Readiness—Medical Research Program (CRRP) Translational Research Award (TRA). This Broad Agency Announcement (BAA) aims to fund research projects that are not related to the development of a specific system or hardware procurement. The research and development funded through this BAA is expected to benefit both military and civilian medical practice and knowledge. The BAA provides detailed information on the CRRP, evaluation criteria, and proposal/application preparation instructions. Extramural applicants, such as academic institutions, biotechnology companies, foundations, and research institutes, are eligible to apply. The submission process involves pre-proposal/pre-application submission through the electronic Biomedical Research Application Portal (eBRAP) and application submission through Grants.gov. The BAA can be downloaded from Grants.gov using the opportunity number HT9425S24CRRPTRA. For more information, refer to the provided link. The primary point of contact is the CDMRP Help Desk, reachable at help@eBRAP.org or 301-682-5507.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
    Intramuscular Injectable Generic Analgesic Ketamine for use in an FDA Approved Emergency Use Authorization
    Active
    Dept Of Defense
    The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking manufacturers for the procurement of intramuscular injectable generic analgesic ketamine intended for use under an FDA-approved Emergency Use Authorization (EUA) for battlefield injuries. The primary objective is to identify suppliers capable of providing ready-to-inject ketamine that meets specific criteria, including being an FDA-approved generic drug available in multidose vials and ready for immediate purchase, without any combination products. This initiative is crucial for enhancing pain management strategies within the military healthcare system, particularly for acute severe pain associated with battlefield injuries. Interested parties must submit a capabilities statement by October 7, 2024, addressing various topics such as FDA status and manufacturing capacity, with all submissions becoming government property. For further inquiries, contact Timothy Kelly at timothy.j.kelly169.civ@health.mil or call 301-619-7806.
    Clinical Study Support for Biomedical Research and Surveillance in Kamphaeng Phet, Thailand
    Active
    Dept Of Defense
    The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking to negotiate a sole source contract with Kamphaeng Phet Hospital in Thailand for clinical study support related to biomedical research and surveillance. The procurement aims to provide comprehensive scientific, technical, regulatory, epidemiological, clinical, laboratory, administrative, database management, quality assurance, and logistical support to the Kamphaeng Phet - Armed Forces Research Institute of Medical Sciences Virology Research Unit (KAVRU) for various biomedical research and surveillance projects. This initiative is crucial for advancing epidemiological and clinical activities in the region, enhancing the understanding and management of health-related issues. Interested parties can contact Jaclyn Svincek at jaclyn.p.svincek.civ@health.mil or Jennifer Jackson at jennifer.c.jackson18.civ@health.mil for further details.
    Intent to Negotiate Sole Source with the University of Rochester Laboratory for Laser Energetics
    Active
    Dept Of Defense
    The Missile Defense Agency (MDA) intends to negotiate a sole source contract modification with the University of Rochester Laboratory for Laser Energetics for the project titled “Pulsed Laser Lethality Studies (PLLS).” This contract modification, valued at $35 million, aims to conduct investigations into pulsed laser lethality, focusing on the development of models and simulations to support the Department of Defense's analysis of various threats across multiple domains, including ground, sea, air, and space. The work will take place in Rochester, New York, with an estimated completion date of May 2028, and interested parties are encouraged to submit any relevant information by October 14, 2024, at 2:00 PM CT to the primary contact, Jessica Milam, at jessica.milam@mda.mil.
    Pioneering Aerospace Capabilities, Engineering and Research
    Active
    Dept Of Defense
    The Department of Defense, through the Air Force Research Laboratory (AFRL), is soliciting proposals for the "Pioneering Aerospace Capabilities, Engineering and Research" initiative, aimed at advancing transformative aerospace technologies. This Broad Agency Announcement (BAA) invites innovative research and development efforts to mature specific technologies to appropriate technology readiness levels (TRL), focusing on enhancing military capabilities and ensuring a decisive advantage for warfighters. The initiative encompasses various areas, including high-speed systems, autonomous controls, and propulsion technologies, with a total funding potential of up to $500 million for multiple contracts over a 20-year period. Interested parties should submit white papers by May 10, 2043, and can direct inquiries to Katherine Ryan at AFRL.RQ.PACERBAA@us.af.mil for further information.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    CHEERS MAA Open Period 2 - All Technical Areas, 10 U.S.C. 4023 - Procurement for Experimental Purposes (ARA)
    Active
    Dept Of Defense
    The Department of Defense, specifically the Air Force Research Laboratory (AFRL) and the United States Air Force School of Aerospace Medicine, issues an open solicitation for experimental purposes, governed by 10 U.S.C. 4023. This multi-step procurement process, referred to as Continuing Human Enabling, Enhancing, Restoring, and Sustaining (CHEERS), seeks innovative solutions in various technical areas related to human effectiveness for national defense. The Air Force invites contractors to submit concise five-page white papers outlining their approaches. These submissions will undergo a review process, and successful candidates will be invited to present detailed proposals. The AFRL retains the discretion to award multiple contracts, IDIQs, or purchases under specific authorities. The focus areas include a wide range of supplies and services, from medical and aeronautical to signal and energy supplies for defense purposes. Offerors should be prepared to provide data items, software, and hardware, although the exact requirements will be established later. The process allows the AFRL to explore diverse solutions, with potential contracts valued at up to $500 million. The legal and contracting clauses detailed in the procurement aim to ensure compliance with federal regulations and manage contractual relationships. These clauses cover various topics, including security, employee rights, and intellectual property, and will be incorporated into the contracts. Contractors will also be responsible for flowing down these clauses to their subcontractors. This solicitation serves as an initial request for information or a draft, as key evaluation criteria and dates are absent. The AFRL seeks to protect proprietary data and may impose security and export control regulations. The submission deadline for the initial white paper step is 30 September 2027. For clarification or questions, interested parties may contact Amber Taylor or Ashlee Green via email.